I-TTBB CAS 124750-51-2 Purity >96.0% (HPLC) I-Irbesartan Intermediate Factory
I-Ruifu Chemical Supply Irbesartan Intermediates:
I-Irbesartan CAS 138402-11-6
I-Cyano-Irbesartan CAS 138401-24-8
I-Trityl Irbesartan CAS 138402-10-5
I-TTBB CAS 124750-51-2
I-Irbesartan Side Chain Hydrochloride CAS 151257-01-1
Igama Lekhemikhali | 5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole |
Omqondofana | I-TTBB;I-BBTT;5-[4'-Bromomethyl-(1,1'-Biphenyl)-2-yl]-1-Triphenylmethyltetrazole;I-N-(Triphenylmethyl)-5-(4'-Bromomethylbiphenyl-2-yl-)tetrazole;Ukungcola kwe-Olmesartan 12;I-Losartan Bromo N1-Trityl Ukungcola |
Inombolo ye-CAS | 124750-51-2 |
Inombolo yeCAT | I-RF-PI1878 |
Isimo Sesitoko | Esitokweni, Amandla Okukhiqiza 150MT/Ngonyaka |
I-Molecular Formula | I-C33H25BrN4 |
Isisindo samangqamuzana | 557.48 |
I-Melting Point | 152.0~155.0℃ |
Ukuminyana | 1.28±0.10 g/cm3 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Emhlophe Kuya Kucishe Emhlophe |
Ukuhlanzeka / Indlela Yokuhlaziya | >96.0% (HPLC) |
Ukulahlekelwa Ekumisweni | <0.50% |
Ukungcola A | <2.00% (HPLC) 5-(4-Methyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole |
Ukungcola B | <2.00% 5-(4'.4'-Dibromomethyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole |
I-Infrared Spectrum | Ivumelana Nesakhiwo |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Irbesartan ephakathi (CAS: 138402-11-6);I-Olmesartan Medoxomil Ukungcola |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
I-5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole (TTBB) (CAS: 124750-51-2) iphakathi kwe-Irbesartan (CAS: 138402-11 -6).I-Irbesartan isetshenziselwa ukwelapha umfutho wegazi ophakeme, kanye ne-nephropathy yesifo sikashukela ene-serum creatinine ephakeme kanye ne-proteinuria (> 300 mg / ngosuku) ezigulini ezinesifo sikashukela sohlobo 2 kanye nomfutho wegazi ophakeme.I-Irbesartan nayo isetshenziswa njenge-ejenti yomugqa wesibili ekwelapheni ukuminyana.I-Irbesartan iyi-angiotensin II receptor antagonist esetshenziswa ikakhulukazi ekwelapheni umfutho wegazi ophakeme.Yasungulwa ngabakwaSanofi Research (manje abayingxenye yeSanofi-Aventis).Imakethwa ngokuhlanganyela yi-Sanofi-Aventis kanye ne-Bristol-Myers Squibb ngaphansi kwamagama okuhweba i-Aprovel, Karvea, ne-Avapro.